{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:38:06Z","timestamp":1789907886030,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jaci.2009.09.012","type":"journal-article","created":{"date-parts":[[2009,12,5]],"date-time":"2009-12-05T04:11:23Z","timestamp":1259986283000},"page":"889-895.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge"],"prefix":"10.1016","volume":"125","author":[{"given":"John A.","family":"Eckman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Sterba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Bochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Donald W.","family":"MacGlashan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbjit S.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2009.09.012_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaci.2008.10.053","article-title":"Therapeutic efficacy of omalizumab","volume":"123","author":"MacGlashan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib2","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1056\/NEJMct055184","article-title":"Omalizumab for asthma","volume":"354","author":"Strunk","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2009.09.012_bib3","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.151.5.2623","article-title":"Humanization of an antibody directed against IgE","volume":"151","author":"Presta","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib4","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1164\/ajrccm.164.supplement_1.2103025","article-title":"Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders","volume":"164","author":"Schulman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2009.09.012_bib5","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"MacGlashan","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib6","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.4049\/jimmunol.162.9.5624","article-title":"Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo","volume":"162","author":"Saini","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab-induced reductions in mast cell Fce psilon RI expression and function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaci.2005.05.035","article-title":"Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge","volume":"116","author":"Ong","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib9","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1016\/j.jaci.2004.12.015","article-title":"Objective monitoring of nasal patency and nasal physiology in rhinitis","volume":"115","author":"Nathan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/0091-6749(92)90293-B","article-title":"Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions","volume":"89","author":"Proud","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM198507113130201","article-title":"Inflammatory mediators in late antigen-induced rhinitis","volume":"313","author":"Naclerio","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2009.09.012_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1081-1206(10)61495-0","article-title":"Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis","volume":"93","author":"Corren","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1183\/09031936.04.00024504","article-title":"Omalizumab inhibits allergen challenge-induced nasal response","volume":"23","author":"Hanf","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2009.09.012_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2006.09.035","article-title":"Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria","volume":"119","author":"Vonakis","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1067\/mai.2001.114653","article-title":"Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils","volume":"107","author":"Saini","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2222.1988.tb02840.x","article-title":"Symptom scores as measures of the severity of rhinitis","volume":"18","author":"Linder","year":"1988","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2009.09.012_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4049\/jimmunol.131.1.429","article-title":"Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay","volume":"131","author":"Hayes","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri2458","article-title":"Newly discovered roles for basophils: a neglected minority gains new respect","volume":"9","author":"Karasuyama","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000112504","article-title":"Basophil histamine release decreases during omalizumab therapy in allergic asthmatics","volume":"146","author":"Noga","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaci.2006.01.012","article-title":"Accuracy of Food and Drug Administration\u2013cleared IgE antibody assays in the presence of anti-IgE (omalizumab)","volume":"117","author":"Hamilton","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.09.012_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jim.2005.06.008","article-title":"Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy","volume":"303","author":"Hamilton","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2009.09.012_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1189\/jlb.0207103","article-title":"Endocytosis, recycling, and degradation of unoccupied FcepsilonRI in human basophils","volume":"82","author":"MacGlashan","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2009.09.012_bib24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1067\/mai.2001.114653","article-title":"Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils","volume":"107","author":"Saini","year":"2001","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909014006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909014006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:22:26Z","timestamp":1758788546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674909014006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0091674909014006"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2009.09.012","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2009.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}